Revista médica de Chile
-
Revista médica de Chile · Sep 2020
Peripheral venoarterial extracorporeal membrane oxygenation for periprocedural Cardiogenic shock during interventional cardiology.
Cardiogenic shock (CS) is uncommon in the cardiac catheterization laboratory (CCL) among patients undergoing coronary angiography. Periprocedural CS is more frequent in high-risk patients and in technically demanding procedures. ⋯ pVA-ECMO should be considered in patients with periprocedural CS as a bridge to recovery. Its use was associated with improved clinical outcomes in this series.
-
Revista médica de Chile · Sep 2020
[Psychometric properties of the Addenbrooke's Cognitive Examination III (ACE-III) for the detection of dementia].
The Addenbrooke's Cognitive Examination III (ACE-III) is widely used for evaluation of dementia. ⋯ ACE-III is a valid, reliable, and useful measure for the clinical detection of dementia. The combined use of Orientation and Memory subscales is proposed as an alternative and time-saving ACE-III indicator.
-
Revista médica de Chile · Sep 2020
[Role of medical students in the accompaniment of patients. Reflections about a true case].
We share the experience of a clinical relationship that arose between a medical student and a patient hospitalized due to a SARS-CoV-2 pneumonia. The analysis of this experience and the discussion of medical students' possible role in patient care suggest that they should be included as members of the health care team during their clinical practice. This would mean a positive contribution for both the patients' care and the students' learning experience.
-
Revista médica de Chile · Sep 2020
Survival rates of advanced estrogen-receptor positive breast cancer. Analysis of 211 cases.
About 80% of breast cancer (BC) cases express estrogen receptor (ER), which has been correlated with good prognosis and response to estrogen deprivation Aim: To characterize ER positive advanced BC (ABC) patients treated at our institution assessing the impact of clinical pre-sentation (stage IV, de novo disease at diagnosis versus systemic recurrence) and BC subtype on survival rates. ⋯ Clinical presentation (stage IV vs. systemic recurrence) and tumor subtype are key determinants of OS in ABC.